500 The prognosis prediction of cutaneous melanoma patients using quantitative real-time PCR from sentinel lymph node
Sentinel lymph node (SLN) biopsy is currently a valuable and reliable diagnostic procedure for precise staging of malignant melanoma (MM) patients. We assessed whether the genetic testing in SLNs from MM patients can be an independent prognostic factor. A retrospective study analysis was conducted for 35 patients (ratio of men to women, 17:18) who underwent SLN biopsy and primary cutaneous melanoma excision in our institution from January 2013 to June 2018. The median patient age was 71 years (range, 13-83 years).
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: S. Sato, E. Okada, M. Nakamura Tags: Melanoma and Other Skin Cancers Source Type: research
More News: Cancer | Cancer & Oncology | Dermatology | Genetics | Melanoma | Skin | Skin Biopsy | Skin Cancer | Study | Women